Sbi Securities Co., Ltd. Beam Therapeutics Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,002 shares of BEAM stock, worth $30,681. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,002
Previous 479
109.19%
Holding current value
$30,681
Previous $9.36 Million
82.19%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$307 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$297 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$271 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$234 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$145 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.15B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...